Home / Inspections / 1251837

FDA Inspection 1251837 — Bayer Healthcare Pharmaceuticals Inc.

Bayer Healthcare Pharmaceuticals Inc. — FEI 2243252

The FDA completed an inspection of Bayer Healthcare Pharmaceuticals Inc. on December 17, 2024 in Whippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 17, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Whippany, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1286004 (NAI Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1277153 (NAI Fri Aug 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1196111 (NAI Wed Feb 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1153395 (NAI Wed Sep 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067092 (NAI Thu Aug 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources